Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line. The company’s pitch is to “Save young cells today, live a longer, better, tomorrow.” It’s a gamble on the frontiers of healthcare technology that has managed […]
View More Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 millionKnowledge is POWER